Inactive Instrument

Charts Puma Biotechnology Inc OTC Bulletin Board

Equities

Real-time Estimate Cboe BZX Other stock markets 11:18:56 2024-05-02 am EDT			5-day change	1st Jan Change
4.905 ^USD	0.00%		0.00%	0.00%

Mar. 20	Puma Biotechnology Plans to Start Breast Cancer Combination Study in Second Half; Shares Rise	MT
Mar. 20	Puma Biotechnology, Inc. Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	CI

ProRealTime Chart